BINARY GENOMICS, INC.

Phoenix, AZ

OncologyGrant-only

Compare Sign in to watch

What changed

NIH R01 · $0.8M · Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis

6mo agoGrant renewalJan 16, 2026Source filing (opens the source filing in a new tab)

Momentum

45no change

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
R44 · $1.0M · non-dilutive
Sep 17, 2024
BINARY GENOMICS, INC. · PI BARRETT, MICHAEL T · NCI · award ends Aug 31, 2027 · Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
NIH RePORTER · NIH RePORTER 11193928 (opens the source filing in a new tab)
Grant
U2C · $953k · non-dilutive
Sep 1, 2022
MASSACHUSETTS GENERAL HOSPITAL · PI SKATES, STEVEN J · NCI · award ends Aug 31, 2028 · Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer
NIH RePORTER · NIH RePORTER 10916219 (opens the source filing in a new tab)
Grant
R01 · $838k · non-dilutive
Jan 1, 2022
CHILDREN'S HOSP OF PHILADELPHIA · PI LI, BO · NCI · award ends Dec 31, 2026 · Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis
NIH RePORTER · NIH RePORTER 11283939 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
new_entity links the grant record at 0.31semantic similarity 83% · same therapeutic area

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

NIH R01 · $0.8M · Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis
6mo agoGrant renewalSource (opens the source filing in a new tab)
NIH U2C · $1.0M · Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer
10mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R44 · $1.0M · Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
11mo agoGrant renewalSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

R44 · $1.0M · non-dilutive

U2C · $953k · non-dilutive

R01 · $838k · non-dilutive